BeyondSpring, Inc. (BYSI)
1.98
-0.01
(-0.50%)
USD |
NASDAQ |
Dec 16, 16:00
1.89
-0.09
(-4.55%)
After-Hours: 06:26
BeyondSpring Research and Development Expense (Quarterly): 1.039M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 75.17M |
| Travere Therapeutics, Inc. | 51.89M |
| Xenetic Biosciences, Inc. | 0.7565M |
| KalVista Pharmaceuticals, Inc. | 11.99M |
| Solid Biosciences, Inc. | 38.86M |